Nervous system: subclinical target of SARS-CoV-2 infection
J Neurol Neurosurg Psychiatry
.
2020 Sep;91(9):1010-1012.
doi: 10.1136/jnnp-2020-323881.
Epub 2020 Jun 23.
Authors
Sara Mariotto
1
,
Alessia Savoldi
2
,
Katia Donadello
3
,
Serena Zanzoni
4
,
Silvia Bozzetti
1
,
Sara Carta
1
,
Cecilia Zivelonghi
1
,
Daniela Alberti
1
,
Francesco Piraino
5
,
Pietro Minuz
6
,
Domenico Girelli
7
,
Ernesto Crisafulli
7
,
Simone Romano
6
,
Denise Marcon
6
,
Giacomo Marchi
7
,
Leonardo Gottin
8
,
Enrico Polati
3
,
Paolo Zanatta
9
,
Salvatore Monaco
1
,
Evelina Tacconelli
2
,
Sergio Ferrari
10
Affiliations
1
Neurology Unit, Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, Verona, Italy.
2
Infectious Disease Section, Department of Diagnostic and Public Health, University of Verona, Verona, Italy.
3
Department of Anesthesia and Intensive Care B, University of Verona, Verona, Italy.
4
Centro Piattaforme Tecnologiche, University of Verona, Verona, Italy.
5
Quanterix Corporation, Billerica, Massachusetts, USA.
6
Department of Medicine, Section of General Medicine and Hypertension, University of Verona, Verona, Italy.
7
Department of Medicine, Internal Medicine Section D, University of Verona, Verona, Italy.
8
Department of Cardiothoracic Anesthesia and Intensive Care Unit, University of Verona, Verona, Italy.
9
Department of Anesthesia and Intensive Care A, University of Verona, Verona, Italy.
10
Neurology Unit, Department of Neuroscience, Biomedicine, and Movement Sciences, University of Verona, Verona, Italy sergio.ferrari@aovr.veneto.it.
PMID:
32576611
PMCID:
PMC7476308
DOI:
10.1136/jnnp-2020-323881
No abstract available
Keywords:
neurovirology; virology.
Publication types
Letter
Comment
MeSH terms
Betacoronavirus
COVID-19
China
Coronavirus Infections*
Coronavirus*
Humans
Nervous System
Pandemics*
Pneumonia, Viral*
SARS-CoV-2